We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
Anaemia is defined by a low red blood cell count. It is the world’s second leading cause of disability, with 1.6 billion sufferers globally. Although it has multiple causes, once they are identified anaemia is often curable.
Based on proprietary technology developed at Imperial College, Toby’s start-up company Eva Diagnostics is developing two affordable handheld anaemia diagnostic devices.
The first one is AnemiPoint, which can be used to identify the presence of anaemia in patients. The other device AnemiStat will identify different types of anaemia.
This is a market-first development in point-of-care anaemia diagnosis that enables clinicians to provide tailored treatments for patients. Eva Diagnostics plans to focus on the global market and the $1 billion or more spend on anaemia-related costs.
Sustainable construction demands better management of social and environmental impact. To achieve this, reliable, efficient tools are needed to make sense of large volumes of data across the range of related fields.
Qflow is a cloud-based platform that enables construction projects to manage their environmental risk and stay compliant with environmental standards.
Qflow brings together machine learning and the Internet of things to capture and analyse environmental data, making it easier to identify and manage risk. This increases productivity and reduces cost while positively impacting the built environment.
The technology connects to existing, on-site systems to automate real-time data collection and analysis. This leads to better informed decisions, more accurate predictions and the ability to generate standardised reports. It reduces costs associated with delays and mitigation processes caused by unmanaged environmental risk.
Trials have shown that Qualis Flows’ solutions can improve data capture against existing competitors by over 100%. Four pilot programmes are scheduled for spring 2019 to further validate the technology’s use in monitoring aspects such as waste, noise, air quality and vibration.
Brittany Harris brings significant experience in civil engineering as she leads a multi-skilled team of engineers, environmental professionals and software architects as Qualis Flow brings its solutions to market.
Wearable technologies are making a massive impact on society, beginning to blur the boundary between human and machine. It is also an exploding commercial market set to be worth $12.6 billion by 2018.
The next generation of lightweight, high performance machines will rely on technologies that are capable of bringing the user as close to a device as possible.
Peiman has created the first reported nano-display device that uses both optical and electronic property modulation in Phase Change Materials. Peiman’s company, Bodle Technologies, spun out of Oxford University in November 2015, to further advance this technology.
An entirely new class of ultra-thin, ultra-high resolution displays with nanosecond access speed and no power consumption in static mode is now under development by his team.
This revolutionary display will initially target the rapidly growing microdisplay market compact, projection based displays used in emerging near-eye applications like Google Glass. The first prototypes are currently under development, with a small working device set to be ready within the next 12 months.
A large part of improving transport involves using real-time data on commuter behaviour to design transport networks that can predict, adapt, respond and prevent congestion - before it happens.
Yang has developed an intelligent camera system that gives real-time insight into traffic and commuter behaviour. By combining machine learning with the latest advances in high performance computing, the system produces a unique method of classifying and identifying images in real time.
It is the first camera that can accurately identify cyclists among other traffic, enabling transport operators to observe how cyclists use a city. This means cities can effectively target investment in cycling and create cyclist-responsive smart traffic lights and smart signage.
It also has potential applications in everything from real-time traffic counting to crowd management and security. The technology is being used right now to map how commuters move around railway stations, how buses are really used and to generate insights from the humble car park.
His company, Vivacity Labs, is now working with several major transport operators and already has over 100 cameras in use across Britain.
Chief Product Officer, Mirada Medical Ltd
Mirada Medical uses deep learning technology to develop medical imaging software that improves treatment and care for patients with cancer and other diseases. Its software automates tasks and processes in a range of clinical work, including diagnostic imaging, radiation therapy and interventional oncology, thereby helping to optimise workflows, save time and improve consistency.
The company has developed a range of accessible solutions that easily fit within existing platforms and technologies. Mirada Medical’s products have been installed in over 2,000 hospitals, imaging centres and cancer centres worldwide, supporting clinicians to make better decisions and deliver personalised care. One of its products, developed to optimise treatment for patients undergoing radiotherapy, offers significant time savings when compared to similar technologies.
As Chief Product Officer, Sarah Bond aims to strategically increase revenue and market share through the development of innovative products that will help the company to retain its competitive advantage.
Supported by the SME Leaders Programme, Sarah Bond will have access to workshops, training, mentoring and networking opportunities to help strengthen the skills needed to lead a talented, growing team. This will help her to deliver a complex and ambitious business plan for growth in the rapidly evolving market of artificial intelligence for healthcare.
Visit Mirada's website here.
CTO, Humanising Autonomy
Humanising Autonomy develops software solutions targeting the human-centred implementation of autonomous technology in the road safety sector. The company combines expertise in artificial intelligence (AI) and behavioural psychology to better understand the range of complex human behaviours. It uses this knowledge to predict the actions of vulnerable road users such as cyclists and pedestrians, so that autonomous systems can operate with greater safety.
Estimates suggest a two second warning could help prevent up to 90% of all collisions between vehicles and hazards that may lie ahead of them. Humanising Autonomy is building a large, diverse and global data set of human behaviours that takes into account culture and context. Using novel approaches in AI, this data will be used to deliver real-time predictions for different automated driving systems to make roads safer.
In 2019, the start-up partnered with Arriva London and Transport for London to develop new software for driver-assistance systems to improve safety.
Raunaq Bose, CTO, leads the development of Humanising Autonomy’s core technologies. With support from the SME Leaders Programme, his mission is to manage R&D in a responsive way that integrates the company’s goals with the needs of external customers and investors. Structured learning through the programme will help Raunaq Bose to strengthen his leadership skills as the company looks to integrate its technology into real vehicles in urban environments and laying the foundations for deploying its software more widely.
Visit Humanising Autonomy's website here.
CEO, SurePulse Medical Limited
Technologies developed at SurePulse help advance the care of newborns by providing easier access to relevant data. This helps make better clinical decisions in time-critical situations.
Around 10% of babies need some form of stabilisation and resuscitation at birth, equating to around 500,000 babies born in Europe each year. Heart rate is the best indicator of resuscitation success but current methods for heart rate monitoring, such as stethoscopes, can lead to delays and errors. SurePulse Medical’s first product, the SurePulse VS, is a vital sign monitoring system that improves clinicians’ ability to make timely decisions about care pathways. Launched in Europe in 2019, the SurePulse VS is designed for comfort and ease-of-use with sensors embedded in a cap for the baby that provides continuous, accurate vital sign data.
Dr James Carpenter, CEO, has successfully led the company through the early development of the technology and clinical trials. Support from the SME Leaders Programme comes at a pivotal stage as SurePulse transitions from a focus on technology development to one seeking commercial sales and growth.
Dr Carpenter aims to leverage opportunities through the programme to support him with product commercialisation, to help lead a talented, self-driven team and prioritise options that match the needs of a rapidly growing business.
Visit SurePulse Medical's website here.
Drones can be used to significantly reduce time, cost and risk of structural surveying and inspection, but they generate large quantities of image-related data that can be costly and resource-intensive to process.
TRIK has developed software that makes drone use for surveying and inspection more accessible. It takes photos and videos captured by drones and automatically turns them into an interactive 3D model that acts as a twin of the real structure.
The technology opens up new possibilities for engineers to visualise sites and structures. Its interactive 3D models can be used to generate insights and also double as a database. They can be used for fast and efficient search, measurement, analysis and comment without the need to visit the actual structure.
It can make drone photography more efficient with processes for auto-tagging images and mapping changes across time. This supports surveyors, asset managers and engineers by making it easier to detect structural changes, predict failure, evaluate risk and maintain sites.
Drone-related services are projected to grow dramatically in the next five years. For example, growth for drone software in asset monitoring and inspection is predicted to reach $7.5 billion by 2022.
Led by Dr Pae Natwilai, an innovator selected
for the Forbes 30 Under 30 Europe Industry list in 2018, TRIK is working with
companies to scale its systems and impact the global market for drone software.
It aims to achieve this by making drone survey and inspection more accessible,
without the need for significant technical expertise.
Dr Natwilai was awarded a 2018 Enterprise Fellowship to support her in bringing TRIK’s solutions to market. TRIK is also funded by Zoopla founder, Alex Chesterman, and LoveFilm founder, Simon Franks.
CEO and Co-founder, Aceleron
Lithium batteries are often discarded with up to 80% of life left. The way they are manufactured limits their capacity for being repurposed. Aceleron aims to change this by delivering services and manufacturing a range of lithium batteries that are easier to repair and recycle using non-permanent assembly methods.
Aceleron’s patented technology makes energy storage more likely by promoting re-use and re-manufacture rather than disposal, leading to reduced lifetime costs. Its circular economy solutions are designed for ease of use at home and in commercial systems. They can also be used for solar energy storage.
Batteries made by Aceleron are lightweight yet robust enough to endure harsh environments, providing an accessible source of energy wherever needed. Current products include residential energy systems for use in places such as the Caribbean that enable efficient energy storage with improved resilience to natural disasters.
Dr Amrit Chandan, CEO, oversees the company’s vision and mission He is responsible for developing strategic partnerships with investors and organisations such as the Shell Foundation. With support from the SME Leaders Programme, Dr Chandan aims to build capacity to scale an international team with commercial and technical expertise, while maintaining a company culture that has a focus on strong results and progress.
Visit Aceleron's website here.
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
Professor May has over 45 years' experience in transport planning and traffic engineering. He has been a professor at Leeds since 1977, and has served as Director of the Institute for Transport Studies, Head of the Department of Civil Engineering, Dean of the Faculty of Engineering and Pro-Vice Chancellor for Research. Between 1985 and 2001 he maintained a link between research and teaching at Leeds and practical experience in consultancy with MVA Ltd for which he was Director of Transport Policy.
Prior to 1977 he spent ten years with the Greater London Council, where he was responsible for policy on highways, traffic management and transport-related land use planning for the capital. He managed major studies on traffic restraint, parking policy and motorway traffic control during his time there.
Anthony was elected to a fellowship of the Royal Academy of Engineering in 1995, and awarded the OBE for services to transport engineering in 2004. He retired in 2009 but is still active in research, consultancy and professional development. He served as President of the World Conference on Transport Research Society between 2007 and 2013. He has until recently been Editor in Chief of the European Transport Research Review and Secretary General of the World Conference on Transport Research Society.
John is currently Chair of the Water Informatics Science & Engineering Centre for Doctoral Training (WISE CDT) advisory board where he provides guidance on strategic development, direction and future sustainability.
He joined Severn Trent Water on its foundation in 1974 and held a number of senior roles until his retirement at the end of December 2004. He has served as a director of Severn Trent plc; Severn Trent Water Ltd; and was a non-executive director of the North American subsidiary together with a number of other non-executive positions; Board member of the Water Industry Commission for Scotland; Chairman of the West Midlands Innovation and Technology Council; Chairman of the Development Forum for the Infrastructure Conditions of Contract; Chairman of the Civil Engineering Standard Method of Management Panel. He also works as an independent consultant.
He is a Past Master of the Worshipful Company of Engineers and is currently their Treasurer.
John is a Chartered Civil Engineer and was elected a Fellow of the Royal Academy of Engineering in 1997. He was made a Fellow of the City & Guilds of London Institute in 2000 and awarded an OBE for services to Engineering and The Water Industry in December 2004.
Christopher is Professor of Biotechnology and Director of the Cambridge Academy of Therapeutic Sciences at the University of Cambridge.
His main research interests cover areas of healthcare biotechnology including biopharmaceuticals, diagnostics and sensors, ageing and medical microbiology. The work is highly multi-disciplinary, encompassing biochemistry, microbiology, chemistry, electrochemistry, physics, electronics, medicine and chemical engineering, but also covering the entire range from pure science to strategic applied science, much of which has significant commercial applications.
He has carried out research in the area of biosensors, biopharmaceuticals, and enzyme, protein and microbial technology.
Professor Lowe has been the driving force for the establishment of 11 spin-out companies with a current market capitalisation of well over $1.5 billion, and has been awarded numerous national and international prizes and distinctions. His research has been recognised by over 20 major national and international awards. He is a Fellow of the Royal Academy of Engineering (2005) and is also a Fellow at Trinity College.
"I vowed to take matters into my own hands and exploit technologies developed in my own laboratories myself. I have unique experience of this approach in the UK and hence my title, the Most Entrepreneurial Scientist of the UK.”
Professor Jon Cooper holds the Wolfson Chair of Bioengineering (Biomedical Engineering) and is responsible for Glasgow University’s Knowledge Exchange strategy. He manages the university’s relationships with its strategic partners in industry, the NHS, government and charities.
Jon is responsible for the university’s enterprise activities which includes the promotion of spinout companies. He has been involved as an academic founder of three spin-out companies in the fields of medical diagnostics, drug delivery and new medicines discovery: Modedx; SAWdx and Clyde Biosciences.
His research group is currently looking at using phononic structures to shape how sound interacts with fluids. Applications are in varying stages of development and include ‘silent’ underwater motors; new diagnostics for infectious diseases; sample processing for next generation gene sequencing tools and targeted drug delivery.
Jon was elected as a Fellow of the Royal Society of Edinburgh (2001) and a Fellow of the Royal Academy of Engineering (2004). He holds an ERC advanced investigator award, a Royal Society Merit award and is an EPSRC Fellow.
"Focus above all else on excellence – whether this be in publications, knowledge exchange & innovation, teaching or supervision. Try to do one thing really well."
Nick is Professor of Regenerative Medicine Manufacture at Loughborough University and Director of the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine.
Nick has experience in regenerative medicine development building on a career in industry as a chemist and chemical engineer. Regenerative medicine is the application of living cells and tissues to resolve disease or injury. It has the potential to revolutionise healthcare. It has been named by the government as one of the priority technologies for UK competitiveness. The market has a global value estimated to be worth $20 billion by 2025.
Nick is a Chartered Chemist and a Chartered Chemical Engineer, and he has spent a significant amount of his career working within Smith & Nephew. Nick also has experience in quality assurance, process design, regulatory affairs and economic analysis.
His specialties include: project cost projections and cost control, advice to grant funding bodies, set up and management of cleanroom facilities and pilot plant, application of healthcare regulations to new medical product development, project planning and control, the construction of efficient Quality Management Systems for medical research programmes.
He was made Fellow of the Royal Academy of Engineering in 2011.
David Ball’s career has involved roles as a CEO for six businesses, chairing three publicly quoted companies, and positions as executive director on the boards of over 65 companies across the world.
David’s key experience lies in creating business success in established businesses which have failed and in start ups, with particular expertise in strategic business development, effective and efficient operational management of both large and small businesses, and managing major business transforming R&D. He has also served on the boards of numerous UK trusts, trade associations and public arts and industry bodies.
He was elected a Fellow of the Royal Academy of Engineering (FREng) in 1998.
"It’s rewarding to work with enthusiastic and dedicated young people who have great ideas and inherent capability but lack experience of business. Knowing I’ve had an influential role as an integral part of the team in bringing about subsequent commercial and personal successes is so satisfying for a mentor.”
Bill was previously Chief Scientist and Head of Research of ICL/FUJITSU and Chairman of the ECRC (European Computer Research Centre) in Munich.
Bill was an advisor to two International Governments on Science and Technology Strategies. He has also had many advisory roles to the European Commission on Science and Technology initiatives especially around biocomputing.
He is currently interested in the security of embedded controllers in scientific and engineering systems and he is an advisor to several tech startups. He was elected a Fellow of the Royal Academy of Engineering in 1998.
Ian is known worldwide as an authority on microdisplay technology, systems and applications. He describes himself as an "academic, innovator and entrepreneur."
Today he is employed by the University of Edinburgh as its Head of the Institute for Integrated Micro and Nano Systems (IMNS) and also acts as an independent consultant with pre-spin-out technology projects and early stage technology companies. He was a force in the pre-spin-out stage of Sofant; is Chairman of PureVLC; advisor to Holoxica and has mentored the management at Optoscribe.
Ian is an Associate Editor of the Journal of the Society for Information Display and sits on the technical program committee of the International Solid State Circuits Conference, the International Displays Research Conference and the Society for Information Display's Annual International Symposium.
His specialities include: electronic information displays, photonic and optoelectronic devices, components and systems.
Recent personal recognition includes Ernst & Young Emerging Entrepreneur of the Year, Scotland (2003); Fellow of the Royal Society of Edinburgh (2004); Gannochy Medal for Innovation winner (2004); Fellow of the Institute of Physics (2008); Appointed to the Scottish Science Advisory Council (2008) and elected a Fellow of the Royal Academy of Engineering (FREng) in 2008.
If you want to know what will be on our roads in 5, 10 or 50 years time, Neville is the man companies and governments alike go to.
Neville has been the Chief Technology & Innovation Officer for Ricardo plc since 2009 when he joined the company fresh out of Imperial College in 1982. He is responsible for developing the future global vision of automotive and energy technology at Ricardo and for the strategy and future direction of research and development. He is also Chair of the Advisory Group at Advanced Propulsion Centre UK.
Throughout his time with Ricardo he has been strongly associated with innovation and technology development including the design, management and execution of the company's significant and sector-leading internally funded research. In this work he has been highly influential in chairing the Ricardo Technology Steering Group and has led many initiatives to forge technology and innovation research collaborations with government, academia and industrial partners.
He is Director of CENEX, the UK Centre of Excellence for Low Carbon Vehicles and Fuel Cells; Chair, Advisory Group at Advanced Propulsion Centre UK; Deputy Chair of the UK Automotive Council Technology Group; Member of the UK Energy Research Partnership; Board member and past chairman of the UK Low Carbon Vehicle Partnership; Member of the UK RAC Foundation Public Policy Committee; Visiting Professor at the University of Brighton; Founder board member of the European Automotive Research Partners Association and Vice Chairman from 2002 to 2008; elected Vice Chairman of the European Road Transport Research Advisory Council (ERTRAC); Member of the advisory board for the European Green Vehicle Initiative and was elected a Fellow of the Royal Academy of Engineering (FREng) in 2011.